Latest News

GeoVax Reports Promising Results for Lassa Fever Vaccine
Single-Dose Vaccine Conferred 100% Protection in Lethal Challenge Model GeoVax Labs, Inc. (OTCQB: G...
Continue Reading...
GeoVax Awarded NIH Grant for Zika Vaccine
Supports Advanced Preclinical Testing in Preparation for Human Clinical Trials GeoVax Labs, Inc. (O...
Continue Reading...
GeoVax to Conduct Partnering Meetings During BIO International Convention June 19-22
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today ...
Continue Reading...